BC
Bradley Canino Stifel Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Syndax Pharmaceuticals
SNDX
$1.36B
| $15.73 | $34 |
116%
upside
| Buy |
4 Sep ‘25
6 days ago |
|
2
Black Diamond Therapeutics
BDTX
$183M
| $3.21 | $15 |
367%
upside
| Buy |
7 Mar ‘25
6 months ago |
|
3
ALX Oncology
ALXO
$62.7M
| $1.17 | $1.50 |
28%
upside
| Hold |
7 Mar ‘25
6 months ago |
|
4
Cullinan Oncology
CGEM
$382M
| $6.47 | $19 |
194%
upside
| Buy |
28 Feb ‘25
6 months ago |
|
5
Relay Therapeutics
RLAY
$700M
| $4.06 | $23 |
467%
upside
| Buy |
27 Feb ‘25
6 months ago |
|
6
Arvinas
ARVN
$575M
| $7.83 | $51 |
551%
upside
| Buy |
12 Feb ‘25
7 months ago |
|
7
Janux Therapeutics
JANX
$1.46B
| $24.31 | $115 |
373%
upside
| Buy |
3 Dec ‘24
9 months ago |
|
|
8
Syndax Pharmaceuticals
SNDX
$1.36B
| $15.73 | $41 |
161%
upside
| Buy |
14 Oct ‘24
11 months ago |
|
9
Kura Oncology
KURA
$709M
| $8.17 | $19 |
133%
upside
| Hold |
14 Oct ‘24
11 months ago |
|
10
Celcuity
CELC
$2.37B
| $55.93 | $42 |
25%
downside
| Buy |
7 Oct ‘24
11 months ago |
|
11
Summit Therapeutics
SMMT
$13.1B
| $17.61 | $40 |
127%
upside
| Buy |
25 Sep ‘24
11 months ago |
|
12
Nuvalent
NUVL
$5.66B
| $78.50 | $135 |
72%
upside
| Buy |
16 Sep ‘24
11 months ago |
|
13
Oric Pharmaceuticals
ORIC
$1.02B
| $10.52 | $20 |
90%
upside
| Buy |
6 Sep ‘24
1 year ago |
|
14
Pyxis Oncology
PYXS
$116M
| $1.87 | $10 |
435%
upside
| Buy |
8 Aug ‘24
1 year ago |
|
15
Zentalis Pharmaceuticals
ZNTL
$105M
| $1.46 | $10 |
585%
upside
| Buy |
18 Jun ‘24
1 year ago |
|
16
Merus
MRUS
$5.08B
| $67.13 | $99 |
47%
upside
| Buy |
17 Jun ‘24
1 year ago |
|
17
C4 Therapeutics
CCCC
$188M
| $2.64 | $14 |
430%
upside
| Buy |
9 May ‘24
1 year ago |
|
18
Kymera Therapeutics
KYMR
$3.11B
| $43.48 | $55 |
26%
upside
| Buy |
23 Feb ‘24
1 year ago |
|